PharmGKB summary: sorafenib pathways.
Animals
Antineoplastic Agents
Clinical Trials as Topic
Gene Regulatory Networks
Humans
Neoplasms
Niacinamide
Pharmacogenomic Testing
Pharmacogenomic Variants
Phenylurea Compounds
Sorafenib
